These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6445060)

  • 21. Transfer factor. General aspects.
    Grob PJ
    Acta Neurol Scand Suppl; 1977; 63():217-26. PubMed ID: 322440
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease.
    Kohm AP; Turley DM; Miller SD
    Int Rev Immunol; 2005; 24(5-6):361-92. PubMed ID: 16318987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antilymphocyte globulin in intensive immunosuppression in patients with multiple sclerosis].
    Cendrowski W
    Postepy Hig Med Dosw; 1978; 32(4):513-22. PubMed ID: 724575
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunotherapy in infectious disease, autoimmunity and cancer.
    Spitler LE; Dau PC
    Acta Neurol Scand Suppl; 1977; 63():227-37. PubMed ID: 265668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.
    Tischner D; Weishaupt A; van den Brandt J; Müller N; Beyersdorf N; Ip CW; Toyka KV; Hünig T; Gold R; Kerkau T; Reichardt HM
    Brain; 2006 Oct; 129(Pt 10):2635-47. PubMed ID: 16921176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current therapy of multiple sclerosis: "T-cell vaccination"].
    Zipp F; Hohlfeld R
    Nervenarzt; 1994 Jun; 65(6):424-5. PubMed ID: 8072598
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
    Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL; Wiendl H
    Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis.
    Lindsey JW; Hodgkinson S; Mehta R; Mitchell D; Enzmann D; Steinman L
    Ann Neurol; 1994 Aug; 36(2):183-9. PubMed ID: 8053654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of transfer factors in the treatment of multiple sclerosis: a case report.
    Sacks N; Potgieter HJ; Van Rensburg AJ
    S Afr Med J; 1976 Sep; 50(40):1556-8. PubMed ID: 982209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter: Transfer factor in multiple sclerosis.
    Lancet; 1976 Jul; 2(7976):99-100. PubMed ID: 59180
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic immunomodulation in neurology: from hope to reality. Exemplified by multiple sclerosis].
    Schluep M; Regli F
    Praxis (Bern 1994); 1995 Sep; 84(38):1021-4. PubMed ID: 7481299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis.
    Zang YC; Hong J; Tejada-Simon MV; Li S; Rivera VM; Killian JM; Zhang JZ
    Eur J Immunol; 2000 Mar; 30(3):908-13. PubMed ID: 10741408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New therapies for multiple sclerosis--when?
    Waisbren BA
    Wis Med J; 1993 Aug; 92(8):448-50. PubMed ID: 8237027
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunostimulation therapy of disseminated sclerosis].
    Zavalishin IA; Nevskaia OM; Pivovarova AI
    Vrach Delo; 1983 Apr; (4):92-4. PubMed ID: 6603069
    [No Abstract]   [Full Text] [Related]  

  • 36. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
    Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
    J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological treatment in multiple sclerosis.
    Lancet; 1980 Nov; 2(8201):953-4. PubMed ID: 6107593
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic aspects of multiple sclerosis].
    Gonsette RE
    Bull Soc Belge Ophtalmol; 1982; 199-200():275-80. PubMed ID: 7184504
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulation of in vitro generation of cell-mediated cytotoxicity. In vitro induction of suppressor T lymphocytes by thymosin.
    Marshall GD; Thurman GB; Goldstein AL
    J Reticuloendothel Soc; 1980 Aug; 28(2):141-9. PubMed ID: 6447785
    [No Abstract]   [Full Text] [Related]  

  • 40. Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters.
    Jersild C; Platz P; Thomsen M; Dupont B; Svejgaard A; Ciongoli AK; Fog T; Grob P
    Scand J Immunol; 1976; 5(1-2):141-8. PubMed ID: 178047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.